Evidence map›Paper›PMID 36445084›Full record

ArticlemBio2022

Human Cytomegalovirus pUL11, a CD45 Ligand, Disrupts CD4 T Cell Control of Viral Spread in Epithelial Cells.

Samuel A Osanyinlusi, Jasmin Zischke, Roland Jacobs, Eva M Weissinger, Thomas F Schulz, Penelope C Kay-Fedorov

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Adenoviral E3/49K: CD45-targeted immune evasion and therapeutic potential.Frontiers in cellular and infection microbiology · 2026
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Samuel A OsanyinlusiInstitute of Virology, Hannover Medical School, Hannover, Germany.
Jasmin ZischkeInstitute of Virology, Hannover Medical School, Hannover, Germany.
Roland JacobsDepartment of Rheumatology and Clinical Immunology, Hannover Medical School, Hannover, Germany.
Eva M WeissingerGerman Center for Infection Research (DZIF, TTU-IICH), Hannover-Braunschweig Site, Hannover, Germany.
Thomas F SchulzInstitute of Virology, Hannover Medical School, Hannover, Germany.ORCID 0000-0001-8792-5345
Penelope C Kay-FedorovInstitute of Virology, Hannover Medical School, Hannover, Germany.ORCID 0000-0002-1162-6952
Medizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human cytomegalovirus (HCMV) encodes numerous immunomodulatory genes that facilitate its persistence. Previously described mechanisms by which HCMV avoids T cell control typically involve evasion of detection by infected cells. Here, we show that the virus also inhibits T cells directly via an interaction between the pUL11 glycoprotein on infected cells and the CD45 phosphatase on T cells. The antiviral functions of CD4 T cells are impaired as a result of this interaction, largely via induced interleukin 10 (IL-10) secretion in the CD4 T cell central memory compartment, resulting in enhanced viral spread. This establishes CD45 as an inhibitory receptor that regulates antiviral T cell functions and has parallels with the manipulation of natural killer (NK) cells by HCMV. By coculturing donor T cells with HCMV-infected epithelial cells, we observed that CD4 T cells can respond to epithelial cell antigen presentation and can control HCMV spread via cytolytic and cytokine-dependent mechanisms. pUL11 impairs both mechanisms. We showed that pUL11-induced IL-10 secretion requires IL-2, mTOR, and T cell receptor signaling. This characterization of the effects of the pUL11-CD45 interaction may allow for the development of new antiviral therapies and treatments for inflammatory disorders.

Indexed as

CD4-Positive T-LymphocytesCytomegalovirusAntiviral AgentsEpithelial CellsGlycoproteinsHumansInterleukin-10Leukocyte Common AntigensLigandsAntiviral AgentsGlycoproteinsInterleukin-10Leukocyte Common AntigensLigandsCD45cytomegalovirusHCMVIL-10T cells

Identifiers

PMID36445084
PMCPMC9765415
OpenAlexW4310458730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.